nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Blepharitis—Donepezil—Alzheimer's disease	0.0256	0.0293	CcSEcCtD
Metipranolol—Blepharitis—Memantine—Alzheimer's disease	0.0233	0.0266	CcSEcCtD
Metipranolol—Blepharitis—Rivastigmine—Alzheimer's disease	0.0228	0.0261	CcSEcCtD
Metipranolol—Atrial fibrillation—Galantamine—Alzheimer's disease	0.0156	0.0178	CcSEcCtD
Metipranolol—Arthritis—Galantamine—Alzheimer's disease	0.0152	0.0174	CcSEcCtD
Metipranolol—Abnormal vision—Donepezil—Alzheimer's disease	0.0138	0.0157	CcSEcCtD
Metipranolol—Abnormal vision—Memantine—Alzheimer's disease	0.0125	0.0143	CcSEcCtD
Metipranolol—Bronchitis—Galantamine—Alzheimer's disease	0.0123	0.014	CcSEcCtD
Metipranolol—Abnormal vision—Rivastigmine—Alzheimer's disease	0.0122	0.014	CcSEcCtD
Metipranolol—Atrial fibrillation—Donepezil—Alzheimer's disease	0.0121	0.0138	CcSEcCtD
Metipranolol—Arthritis—Donepezil—Alzheimer's disease	0.0118	0.0135	CcSEcCtD
Metipranolol—Atrial fibrillation—Memantine—Alzheimer's disease	0.011	0.0125	CcSEcCtD
Metipranolol—Epistaxis—Galantamine—Alzheimer's disease	0.0107	0.0123	CcSEcCtD
Metipranolol—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.0107	0.0123	CcSEcCtD
Metipranolol—Arthritis—Memantine—Alzheimer's disease	0.0107	0.0122	CcSEcCtD
Metipranolol—Arthritis—Rivastigmine—Alzheimer's disease	0.0105	0.012	CcSEcCtD
Metipranolol—Bradycardia—Galantamine—Alzheimer's disease	0.0104	0.0119	CcSEcCtD
Metipranolol—Rhinitis—Galantamine—Alzheimer's disease	0.0102	0.0117	CcSEcCtD
Metipranolol—Visual impairment—Galantamine—Alzheimer's disease	0.00985	0.0113	CcSEcCtD
Metipranolol—Angina pectoris—Donepezil—Alzheimer's disease	0.00964	0.011	CcSEcCtD
Metipranolol—Bronchitis—Donepezil—Alzheimer's disease	0.00952	0.0109	CcSEcCtD
Metipranolol—Angina pectoris—Memantine—Alzheimer's disease	0.00875	0.01	CcSEcCtD
Metipranolol—Tension—Galantamine—Alzheimer's disease	0.00873	0.00999	CcSEcCtD
Metipranolol—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.0087	0.00995	CcSEcCtD
Metipranolol—Myocardial infarction—Donepezil—Alzheimer's disease	0.00865	0.00989	CcSEcCtD
Metipranolol—Nervousness—Galantamine—Alzheimer's disease	0.00864	0.00989	CcSEcCtD
Metipranolol—Bronchitis—Memantine—Alzheimer's disease	0.00864	0.00989	CcSEcCtD
Metipranolol—Conjunctivitis—Donepezil—Alzheimer's disease	0.00858	0.00981	CcSEcCtD
Metipranolol—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00856	0.0098	CcSEcCtD
Metipranolol—Bronchitis—Rivastigmine—Alzheimer's disease	0.00845	0.00967	CcSEcCtD
Metipranolol—Vision blurred—Galantamine—Alzheimer's disease	0.00838	0.00959	CcSEcCtD
Metipranolol—Epistaxis—Donepezil—Alzheimer's disease	0.00832	0.00952	CcSEcCtD
Metipranolol—Bradycardia—Donepezil—Alzheimer's disease	0.00806	0.00922	CcSEcCtD
Metipranolol—Rhinitis—Donepezil—Alzheimer's disease	0.00794	0.00908	CcSEcCtD
Metipranolol—Acute coronary syndrome—Memantine—Alzheimer's disease	0.0079	0.00903	CcSEcCtD
Metipranolol—Palpitations—Galantamine—Alzheimer's disease	0.00786	0.00899	CcSEcCtD
Metipranolol—Myocardial infarction—Memantine—Alzheimer's disease	0.00785	0.00898	CcSEcCtD
Metipranolol—Conjunctivitis—Memantine—Alzheimer's disease	0.00779	0.00891	CcSEcCtD
Metipranolol—Cough—Galantamine—Alzheimer's disease	0.00776	0.00888	CcSEcCtD
Metipranolol—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00773	0.00884	CcSEcCtD
Metipranolol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00768	0.00879	CcSEcCtD
Metipranolol—Hypertension—Galantamine—Alzheimer's disease	0.00768	0.00879	CcSEcCtD
Metipranolol—Visual impairment—Donepezil—Alzheimer's disease	0.00763	0.00873	CcSEcCtD
Metipranolol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00762	0.00871	CcSEcCtD
Metipranolol—Myalgia—Galantamine—Alzheimer's disease	0.00757	0.00867	CcSEcCtD
Metipranolol—Epistaxis—Memantine—Alzheimer's disease	0.00756	0.00864	CcSEcCtD
Metipranolol—Anxiety—Galantamine—Alzheimer's disease	0.00755	0.00864	CcSEcCtD
Metipranolol—Discomfort—Galantamine—Alzheimer's disease	0.00748	0.00856	CcSEcCtD
Metipranolol—Epistaxis—Rivastigmine—Alzheimer's disease	0.00739	0.00846	CcSEcCtD
Metipranolol—Bradycardia—Memantine—Alzheimer's disease	0.00732	0.00838	CcSEcCtD
Metipranolol—Rhinitis—Memantine—Alzheimer's disease	0.00721	0.00825	CcSEcCtD
Metipranolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.00716	0.00819	CcSEcCtD
Metipranolol—Rhinitis—Rivastigmine—Alzheimer's disease	0.00705	0.00807	CcSEcCtD
Metipranolol—Visual impairment—Memantine—Alzheimer's disease	0.00693	0.00793	CcSEcCtD
Metipranolol—Visual impairment—Rivastigmine—Alzheimer's disease	0.00678	0.00776	CcSEcCtD
Metipranolol—Tension—Donepezil—Alzheimer's disease	0.00677	0.00774	CcSEcCtD
Metipranolol—Nervousness—Donepezil—Alzheimer's disease	0.0067	0.00766	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00661	0.00757	CcSEcCtD
Metipranolol—Vision blurred—Donepezil—Alzheimer's disease	0.0065	0.00743	CcSEcCtD
Metipranolol—Somnolence—Galantamine—Alzheimer's disease	0.00645	0.00738	CcSEcCtD
Metipranolol—Tension—Memantine—Alzheimer's disease	0.00614	0.00703	CcSEcCtD
Metipranolol—Nervousness—Memantine—Alzheimer's disease	0.00608	0.00696	CcSEcCtD
Metipranolol—Cough—Donepezil—Alzheimer's disease	0.00602	0.00688	CcSEcCtD
Metipranolol—Tension—Rivastigmine—Alzheimer's disease	0.00601	0.00688	CcSEcCtD
Metipranolol—Hypertension—Donepezil—Alzheimer's disease	0.00595	0.00681	CcSEcCtD
Metipranolol—Nervousness—Rivastigmine—Alzheimer's disease	0.00595	0.00681	CcSEcCtD
Metipranolol—Vision blurred—Memantine—Alzheimer's disease	0.0059	0.00675	CcSEcCtD
Metipranolol—Myalgia—Donepezil—Alzheimer's disease	0.00587	0.00672	CcSEcCtD
Metipranolol—Anxiety—Donepezil—Alzheimer's disease	0.00585	0.00669	CcSEcCtD
Metipranolol—Discomfort—Donepezil—Alzheimer's disease	0.0058	0.00663	CcSEcCtD
Metipranolol—Vision blurred—Rivastigmine—Alzheimer's disease	0.00577	0.0066	CcSEcCtD
Metipranolol—Oedema—Donepezil—Alzheimer's disease	0.00563	0.00644	CcSEcCtD
Metipranolol—Palpitations—Memantine—Alzheimer's disease	0.00553	0.00633	CcSEcCtD
Metipranolol—Cough—Memantine—Alzheimer's disease	0.00546	0.00625	CcSEcCtD
Metipranolol—Palpitations—Rivastigmine—Alzheimer's disease	0.00541	0.00619	CcSEcCtD
Metipranolol—Hypertension—Memantine—Alzheimer's disease	0.0054	0.00618	CcSEcCtD
Metipranolol—Hypersensitivity—Galantamine—Alzheimer's disease	0.00535	0.00612	CcSEcCtD
Metipranolol—Cough—Rivastigmine—Alzheimer's disease	0.00534	0.00611	CcSEcCtD
Metipranolol—Myalgia—Memantine—Alzheimer's disease	0.00533	0.0061	CcSEcCtD
Metipranolol—Anxiety—Memantine—Alzheimer's disease	0.00531	0.00608	CcSEcCtD
Metipranolol—Hypertension—Rivastigmine—Alzheimer's disease	0.00529	0.00605	CcSEcCtD
Metipranolol—Discomfort—Memantine—Alzheimer's disease	0.00527	0.00602	CcSEcCtD
Metipranolol—Myalgia—Rivastigmine—Alzheimer's disease	0.00521	0.00596	CcSEcCtD
Metipranolol—Asthenia—Galantamine—Alzheimer's disease	0.00521	0.00596	CcSEcCtD
Metipranolol—Anxiety—Rivastigmine—Alzheimer's disease	0.0052	0.00594	CcSEcCtD
Metipranolol—Discomfort—Rivastigmine—Alzheimer's disease	0.00515	0.00589	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00513	0.00587	CcSEcCtD
Metipranolol—Oedema—Memantine—Alzheimer's disease	0.00511	0.00585	CcSEcCtD
Metipranolol—Dyspnoea—Donepezil—Alzheimer's disease	0.00502	0.00574	CcSEcCtD
Metipranolol—Somnolence—Donepezil—Alzheimer's disease	0.005	0.00572	CcSEcCtD
Metipranolol—Oedema—Rivastigmine—Alzheimer's disease	0.005	0.00572	CcSEcCtD
Metipranolol—Dizziness—Galantamine—Alzheimer's disease	0.0048	0.00549	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00465	0.00533	CcSEcCtD
Metipranolol—Rash—Galantamine—Alzheimer's disease	0.00458	0.00524	CcSEcCtD
Metipranolol—Dermatitis—Galantamine—Alzheimer's disease	0.00457	0.00523	CcSEcCtD
Metipranolol—Dyspnoea—Memantine—Alzheimer's disease	0.00455	0.00521	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00455	0.00521	CcSEcCtD
Metipranolol—Headache—Galantamine—Alzheimer's disease	0.00455	0.0052	CcSEcCtD
Metipranolol—Somnolence—Memantine—Alzheimer's disease	0.00454	0.0052	CcSEcCtD
Metipranolol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00446	0.0051	CcSEcCtD
Metipranolol—Somnolence—Rivastigmine—Alzheimer's disease	0.00444	0.00508	CcSEcCtD
Metipranolol—Nausea—Galantamine—Alzheimer's disease	0.00431	0.00493	CcSEcCtD
Metipranolol—Hypersensitivity—Donepezil—Alzheimer's disease	0.00415	0.00474	CcSEcCtD
Metipranolol—Asthenia—Donepezil—Alzheimer's disease	0.00404	0.00462	CcSEcCtD
Metipranolol—Hypersensitivity—Memantine—Alzheimer's disease	0.00376	0.00431	CcSEcCtD
Metipranolol—Dizziness—Donepezil—Alzheimer's disease	0.00372	0.00426	CcSEcCtD
Metipranolol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00368	0.00421	CcSEcCtD
Metipranolol—Asthenia—Memantine—Alzheimer's disease	0.00367	0.00419	CcSEcCtD
Metipranolol—Asthenia—Rivastigmine—Alzheimer's disease	0.00359	0.0041	CcSEcCtD
Metipranolol—Rash—Donepezil—Alzheimer's disease	0.00355	0.00406	CcSEcCtD
Metipranolol—Dermatitis—Donepezil—Alzheimer's disease	0.00354	0.00406	CcSEcCtD
Metipranolol—Headache—Donepezil—Alzheimer's disease	0.00352	0.00403	CcSEcCtD
Metipranolol—Dizziness—Memantine—Alzheimer's disease	0.00338	0.00387	CcSEcCtD
Metipranolol—Nausea—Donepezil—Alzheimer's disease	0.00334	0.00382	CcSEcCtD
Metipranolol—Dizziness—Rivastigmine—Alzheimer's disease	0.00331	0.00378	CcSEcCtD
Metipranolol—Rash—Memantine—Alzheimer's disease	0.00322	0.00369	CcSEcCtD
Metipranolol—Dermatitis—Memantine—Alzheimer's disease	0.00322	0.00368	CcSEcCtD
Metipranolol—Headache—Memantine—Alzheimer's disease	0.0032	0.00366	CcSEcCtD
Metipranolol—Rash—Rivastigmine—Alzheimer's disease	0.00315	0.00361	CcSEcCtD
Metipranolol—Dermatitis—Rivastigmine—Alzheimer's disease	0.00315	0.0036	CcSEcCtD
Metipranolol—Headache—Rivastigmine—Alzheimer's disease	0.00313	0.00358	CcSEcCtD
Metipranolol—Acebutolol—CYP2D6—Alzheimer's disease	0.00305	0.202	CrCbGaD
Metipranolol—Nausea—Memantine—Alzheimer's disease	0.00303	0.00347	CcSEcCtD
Metipranolol—Oxprenolol—CYP2D6—Alzheimer's disease	0.00302	0.2	CrCbGaD
Metipranolol—Nausea—Rivastigmine—Alzheimer's disease	0.00297	0.0034	CcSEcCtD
Metipranolol—Alprenolol—CYP2D6—Alzheimer's disease	0.00277	0.183	CrCbGaD
Metipranolol—Metoprolol—CYP2D6—Alzheimer's disease	0.00257	0.17	CrCbGaD
Metipranolol—Pindolol—CYP2D6—Alzheimer's disease	0.00238	0.158	CrCbGaD
Metipranolol—Propranolol—CYP2D6—Alzheimer's disease	0.0013	0.086	CrCbGaD
Metipranolol—ADRB2—G alpha (s) signalling events—CRH—Alzheimer's disease	0.000925	0.00835	CbGpPWpGaD
Metipranolol—ADRB2—Arf6 trafficking events—INS—Alzheimer's disease	0.000911	0.00821	CbGpPWpGaD
Metipranolol—ADRB1—G alpha (s) signalling events—NPS—Alzheimer's disease	0.000897	0.00809	CbGpPWpGaD
Metipranolol—ADRB2—G alpha (s) signalling events—NPS—Alzheimer's disease	0.000877	0.00791	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.000859	0.00774	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.00084	0.00757	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.000836	0.00754	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.000818	0.00738	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.000717	0.00646	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.000701	0.00632	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Other—CCR5—Alzheimer's disease	0.000691	0.00623	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Other—HTR2A—Alzheimer's disease	0.000676	0.0061	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—PYY—Alzheimer's disease	0.000654	0.0059	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—PYY—Alzheimer's disease	0.00064	0.00577	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000595	0.00537	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.000582	0.00525	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR6—Alzheimer's disease	0.000546	0.00492	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR6—Alzheimer's disease	0.000534	0.00481	CbGpPWpGaD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	0.000502	0.00453	CbGpPWpGaD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	0.000491	0.00443	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000467	0.00422	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000457	0.00412	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—GAL—Alzheimer's disease	0.000453	0.00409	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—GAL—Alzheimer's disease	0.000443	0.004	CbGpPWpGaD
Metipranolol—ADRB1—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	0.000435	0.00392	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000428	0.00386	CbGpPWpGaD
Metipranolol—ADRB2—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	0.000425	0.00383	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000418	0.00377	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000408	0.00368	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000399	0.0036	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000397	0.00358	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000389	0.00351	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PYY—Alzheimer's disease	0.000369	0.00333	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PYY—Alzheimer's disease	0.000361	0.00326	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—NPY—Alzheimer's disease	0.000356	0.00321	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—IAPP—Alzheimer's disease	0.000354	0.00319	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—NPY—Alzheimer's disease	0.000348	0.00314	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—IAPP—Alzheimer's disease	0.000346	0.00312	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CRH—Alzheimer's disease	0.000343	0.0031	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CRH—Alzheimer's disease	0.000336	0.00303	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PYY—Alzheimer's disease	0.000336	0.00303	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PYY—Alzheimer's disease	0.000328	0.00296	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—NPS—Alzheimer's disease	0.000326	0.00294	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—NPS—Alzheimer's disease	0.000319	0.00287	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—SST—Alzheimer's disease	0.000311	0.0028	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000308	0.00278	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000307	0.00277	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—SST—Alzheimer's disease	0.000304	0.00274	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—APP—Alzheimer's disease	0.000303	0.00273	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000302	0.00272	CbGpPWpGaD
Metipranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.0003	0.00271	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.0003	0.00271	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—APP—Alzheimer's disease	0.000296	0.00267	CbGpPWpGaD
Metipranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000294	0.00265	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CDK5—Alzheimer's disease	0.000291	0.00262	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CDK5—Alzheimer's disease	0.000285	0.00257	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR6—Alzheimer's disease	0.00028	0.00253	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR6—Alzheimer's disease	0.000274	0.00247	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000263	0.00237	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000257	0.00232	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000257	0.00232	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GAL—Alzheimer's disease	0.000256	0.00231	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000252	0.00227	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GAL—Alzheimer's disease	0.000251	0.00226	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GAL—Alzheimer's disease	0.000233	0.0021	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GAL—Alzheimer's disease	0.000228	0.00205	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TTR—Alzheimer's disease	0.000227	0.00205	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000226	0.00203	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TTR—Alzheimer's disease	0.000222	0.002	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000221	0.00199	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—NPY—Alzheimer's disease	0.000201	0.00181	CbGpPWpGaD
Metipranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000201	0.00181	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CCR5—Alzheimer's disease	0.0002	0.00181	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—IAPP—Alzheimer's disease	0.0002	0.0018	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PYY—Alzheimer's disease	0.000198	0.00179	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—NPY—Alzheimer's disease	0.000197	0.00177	CbGpPWpGaD
Metipranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000197	0.00177	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000196	0.00177	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	0.000196	0.00177	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000196	0.00176	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CRH—Alzheimer's disease	0.000194	0.00175	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	0.000194	0.00175	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000192	0.00173	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	0.00019	0.00171	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—NPS—Alzheimer's disease	0.000184	0.00166	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	0.000183	0.00165	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	0.000182	0.00164	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	0.00018	0.00162	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	0.000179	0.00161	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	0.000178	0.0016	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	0.000176	0.00159	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	0.000176	0.00158	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000176	0.00158	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	0.000172	0.00155	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	0.000172	0.00155	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	0.000172	0.00155	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	0.000172	0.00155	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000172	0.00155	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	0.000171	0.00154	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	0.000168	0.00152	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	0.000168	0.00151	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	0.000167	0.00151	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	0.000167	0.00151	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000166	0.0015	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	0.000165	0.00149	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	0.000163	0.00147	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000163	0.00147	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	0.000162	0.00146	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000161	0.00146	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	0.000159	0.00144	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000159	0.00144	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000158	0.00142	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	0.000156	0.00141	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	0.000156	0.00141	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	0.000155	0.0014	CbGpPWpGaD
Metipranolol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	0.000153	0.00138	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	0.000152	0.00137	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	0.00015	0.00135	CbGpPWpGaD
Metipranolol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	0.00015	0.00135	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	0.000148	0.00134	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	0.000147	0.00133	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000147	0.00132	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	0.000145	0.00131	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000144	0.0013	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000143	0.00129	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	0.000141	0.00127	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	0.000141	0.00127	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	0.000138	0.00124	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	0.000137	0.00124	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	0.000137	0.00124	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	0.000134	0.00121	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	0.000134	0.00121	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	0.000121	0.00109	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000119	0.00108	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	0.000118	0.00107	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000117	0.00106	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000117	0.00105	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	0.000115	0.00103	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000113	0.00102	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000111	0.000998	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000111	0.000998	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000108	0.000978	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000108	0.000977	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	0.000108	0.000973	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	0.000107	0.000967	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000106	0.000956	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	0.000106	0.000952	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	0.000105	0.000946	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	0.000104	0.000939	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000103	0.000926	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	0.000102	0.000919	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000101	0.000907	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	0.0001	0.000906	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	9.87e-05	0.00089	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	9.83e-05	0.000887	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	9.82e-05	0.000886	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	9.7e-05	0.000875	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	9.68e-05	0.000873	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	9.66e-05	0.000871	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	9.61e-05	0.000866	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	9.49e-05	0.000856	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	9.47e-05	0.000854	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	9.42e-05	0.000849	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	9.42e-05	0.000849	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	9.42e-05	0.000849	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	9.38e-05	0.000846	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	9.33e-05	0.000842	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	9.21e-05	0.000831	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	9.21e-05	0.000831	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	9.21e-05	0.000831	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	9.18e-05	0.000828	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	9.17e-05	0.000827	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	9.13e-05	0.000823	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	8.98e-05	0.00081	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	8.81e-05	0.000795	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	8.66e-05	0.000781	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	8.62e-05	0.000777	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	8.47e-05	0.000764	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	8.08e-05	0.000729	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	8.03e-05	0.000724	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	7.9e-05	0.000713	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	7.89e-05	0.000712	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	7.85e-05	0.000708	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	7.85e-05	0.000708	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	7.72e-05	0.000696	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	7.68e-05	0.000693	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	7.46e-05	0.000673	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	7.3e-05	0.000658	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	7.1e-05	0.000641	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	6.95e-05	0.000627	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	6.87e-05	0.00062	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	6.72e-05	0.000606	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	6.59e-05	0.000594	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	6.53e-05	0.000589	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	6.44e-05	0.000581	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	6.4e-05	0.000577	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	6.38e-05	0.000576	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	6.26e-05	0.000565	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	6.24e-05	0.000563	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	6.1e-05	0.00055	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	6.07e-05	0.000547	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	5.94e-05	0.000536	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	5.94e-05	0.000535	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	5.81e-05	0.000524	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	5.54e-05	0.0005	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	5.52e-05	0.000498	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	5.52e-05	0.000498	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	5.47e-05	0.000493	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	5.42e-05	0.000489	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	5.4e-05	0.000487	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	5.4e-05	0.000487	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	5.35e-05	0.000483	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	5.27e-05	0.000475	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	5.21e-05	0.00047	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	5.16e-05	0.000465	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	5.09e-05	0.000459	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	5.09e-05	0.000459	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.98e-05	0.000449	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	4.78e-05	0.000431	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	4.74e-05	0.000428	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	4.72e-05	0.000425	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	4.68e-05	0.000422	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	4.64e-05	0.000418	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	4.64e-05	0.000418	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	4.61e-05	0.000416	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	4.56e-05	0.000411	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	4.54e-05	0.000409	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	4.46e-05	0.000402	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	4.14e-05	0.000373	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	4.05e-05	0.000365	CbGpPWpGaD
Metipranolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.54e-05	0.00032	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	3.51e-05	0.000317	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	3.49e-05	0.000315	CbGpPWpGaD
Metipranolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.47e-05	0.000313	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	3.43e-05	0.00031	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	3.41e-05	0.000308	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	3.23e-05	0.000291	CbGpPWpGaD
Metipranolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	3.22e-05	0.00029	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	3.16e-05	0.000285	CbGpPWpGaD
Metipranolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	3.15e-05	0.000284	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	2.98e-05	0.000269	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	2.91e-05	0.000263	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	2.73e-05	0.000247	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	2.68e-05	0.000241	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	2.25e-05	0.000203	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	2.2e-05	0.000199	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	2.06e-05	0.000186	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	2.02e-05	0.000182	CbGpPWpGaD
Metipranolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	1.9e-05	0.000171	CbGpPWpGaD
Metipranolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	1.86e-05	0.000168	CbGpPWpGaD
